Clinical Studies
A new study co-conducted by thinkstep-anz, Aquaculture NZ, and Ministry for Primary Industries (MPI) has discovered that New Zealand-farmed shellfish have some of the lowest carbon foot-prints of all animal proteins.
Continue reading
The aim of this study was to investigate how changes in the gastrointestinal tract (GIT) microbiota profile may influence nutraceutical efficacy in osteoarthritis (OA) and allow the formulation of a hypothesis that explains in part the inconsistent and contentious findings from OA clinical studies with green-lipped mussel (GLM) and glucosamine.
Continue reading
The aim of this study was to investigate the efficacy of a high-dose New Zealand green-lipped mussel (GLM) extract in patients diagnosed with Osteoarthritis of the knee and assess GLM impact on Gastrointestinal function. Results demonstrated that green-lipped mussel significantly improved knee joint pain, stiffness and mobility.
Perna canaliculus (Green-Lipped Mussel) is found only in New Zealand waters and is cultivated and manufactured for both the food and nutraceutical industry world-wide. P. canaliculus has traditionally been used as a therapeutic to treat various arthralgias in both humans and animals; however, clinical research reports provide conflicting results.
Continue reading